Detalhe da pesquisa
1.
Clinical validation of circulating GDF15/MIC-1 as a marker of response to docetaxel and survival in men with metastatic castration-resistant prostate cancer.
Prostate
; 84(8): 747-755, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38544345